The Pharmaceutical Triple Aim
Higher Medication Adherence
- Increases Revenue and EPS for Pharma
- Improves Patient Outcomes
- Lowers Healthcare Costs
The numbers in HealthPrize’s newest investigative report tell the story: higher adherence can have a significant impact on pharma’s earnings-per-share (EPS) growth – up to 45% for one company – and it can do so relatively quickly.
Find out how your company ranked: get the report →